J. Patoiseau

发表

Investigation of the Mechanism by which Ketanserin Prolongs the Duration of the Cardiac Action Potential

F. Colpaert, B. Grand, J. Talmant, 1995, Journal of cardiovascular pharmacology.

Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine.

Robert V Farese, S. Strom, J. Fung, 2000, The Journal of biological chemistry.

KC 12291: an atypical sodium channel blocker with myocardial antiischemic properties.

F. Colpaert, A. Coulombe, J. Patoiseau, 2006, Cardiovascular drug reviews.

Study of the Interaction of Lubeluzole with Cardiac Sodium Channels

J. Talmant, J. Rieu, J. Patoiseau, 2003, Journal of cardiovascular pharmacology.

F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet.

F. Colpaert, D. Junquéro, F. Bruniquel, 2001, Atherosclerosis.

Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture.

F. Colpaert, B. Staels, G. Torpier, 2001, Biochemical pharmacology.

PPAR activators and COX inhibitors selectively block cytokine-induced COX-2 expression and activity in human aortic smooth muscle cells.

D. Junquéro, J. Patoiseau, F. Lestienne, 2009, European journal of pharmacology.

Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages.

F. Colpaert, D. Junquéro, J. Patoiseau, 2004, DNA and cell biology.

HUMAN aP2 GENE PROMOTER-DRIVEN REPORTER ASSAY DISCRIMINATES NON-LIPOGENIC PPAR γ LIGANDS

T. Wurch, J. Patoiseau, L. Puech, 2004 .

Prevention by specific chemical classes of α1‐adrenoceptor antagonists of veratrine‐contractures in rat left atria independently of α1‐adrenoceptor blockade

B. Grand, J. Patoiseau, G. John, 1994 .

Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.

F. Colpaert, D. Junquéro, P. Oms, 2001, Biochemical pharmacology.

Synthesis and bradycardic activity of a series of substituted 3-aminoalkyl-2,3-dihydro-4H-1,3-benzoxazin-4-ones as potent antiischemics

J. Rieu, J. Patoiseau, D. Bigg, 1993 .

Characterization of polymorphs and solvates of 3-amino-1-(m-trifluoromethylphenyl)-6-methyl-1H-pyridazin-4-one.

J. Patoiseau, J. Ribet, D. Bigg, 1992, Journal of pharmaceutical sciences.

Hyperacidic media. A novel route to 13α-steroids

J. Patoiseau, J. Jacquesy, R. Jacquesy, 1973 .

REACTIONS IN HYPERACID MEDIA. XXV. OXIDATION BY OZONE- A NEW ROUTE TO 6- OR 7-OXO STEROIDS

J. Patoiseau, J. Jacquesy, 1977 .

HYPERACIDIC MEDIA, A NOVEL ROUTE TO 13ALPHA-STEROIDS

J. Patoiseau, J. Jacquesy, R. Jacquesy, 1974 .

PPARα and PPARδ activators inhibit cytokine-induced nuclear translocation of NF-κB and expression of VCAM-1 in EAhy926 endothelial cells

F. Colpaert, D. Junquéro, A. Delhon, 2002 .

Human Adipocyte Fatty Acid-Binding Protein (aP2) Gene Promoter-Driven Reporter Assay Discriminates Nonlipogenic Peroxisome Proliferator-Activated Receptor γ Ligands

T. Wurch, D. Junquéro, J. Patoiseau, 2004, Journal of Pharmacology and Experimental Therapeutics.

5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.

P. Pauwels, F. Colpaert, W. Koek, 2001, European journal of pharmacology.

F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.

P. Pauwels, C. Palmier, F. Colpaert, 1998, The Journal of pharmacology and experimental therapeutics.

Evidence for partial agonist properties of daltroban (BM 13,505) at TP receptors in the anæsthetized open-chest rat

F. Colpaert, J. Valentin, J. Rieu, 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

Intrinsic activity of the non‐prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo

F. Colpaert, J. Maclouf, J. Valentin, 1995, British journal of pharmacology.

Synthesis of novel indolizine derivatives

J. Patoiseau, B. Bonnaud, D. Bigg, 1991 .

PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells.

F. Colpaert, D. Junquéro, A. Delhon, 2002, European journal of pharmacology.

[Crystalline polymorphism of eflucimibe].

J. Autret, J. Patoiseau, R. Pena, 2002, Annales pharmaceutiques francaises.